Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
BörsenkürzelLH
Name des UnternehmensLabcorp Holdings Inc
IPO-datumApr 24, 1991
CEOSchechter (Adam H)
Anzahl der mitarbeiter70000
WertpapierartOrdinary Share
GeschäftsjahresendeApr 24
Addresse358 S Main St
StadtBURLINGTON
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl27215
Telefon13362291127
Websitehttps://www.labcorp.com/
BörsenkürzelLH
IPO-datumApr 24, 1991
CEOSchechter (Adam H)